Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1755 ARTÍCULOS , VIENDO DEL 1726 AL 1740

Are Care-Recipient Outcomes Attributable to Improved Caregiver Well-Being? A Cluster-Randomized Controlled Trial of Benefit-Finding Intervention

Cheng ST, Chan WC, Lam LCW.

Am J Geriatr Psychiatry. 2022 Aug;30(8):903-913. doi: 10.1016/j.jagp.2021.08.009. Epub 2021 Aug 28.

Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment

Pathak N, Vimal SK, Tandon I, Agrawal L, Hongyi C, Bhattacharyya S.

Metab Brain Dis. 2022 Jan;37(1):67-104. doi: 10.1007/s11011-021-00800-w. Epub 2021 Nov 1.

Advancements and future directions in research of the roles of insulin in amyloid diseases

Miller Y.

Biophys Chem. 2022 Feb;281:106720. doi: 10.1016/j.bpc.2021.106720. Epub 2021 Nov 17.

A heterozygous de novo PSEN1 mutation in a patient with early-onset parkinsonism

Chen Y, Liu P, Xie F, Wang B, Lin Z, Luo W.

Neurol Sci. 2022 Feb;43(2):1405-1409. doi: 10.1007/s10072-021-05726-w. Epub 2021 Nov 29.

Lewy Body Dementias: Controversies and Drug Development

Chiu SY, Bowers D, Armstrong MJ.

Neurotherapeutics. 2022 Jan;19(1):55-67. doi: 10.1007/s13311-021-01161-z. Epub 2021 Dec 2.

Safety and Efficacy of Mevidalen in Lewy Body Dementia: A Phase 2, Randomized, Placebo-Controlled Trial

Biglan K, Munsie L, Svensson KA, Ardayfio P, Pugh M, Sims J, Brys M.

Mov Disord. 2022 Mar;37(3):513-524. doi: 10.1002/mds.28879. Epub 2021 Dec 2.

Biosensor approaches on the diagnosis of neurodegenerative diseases: Sensing the past to the future

Karaboğa MNS, Sezgintürk MK.

J Pharm Biomed Anal. 2022 Feb 5;209:114479. doi: 10.1016/j.jpba.2021.114479. Epub 2021 Nov 24.

Composition of intestinal flora affects the risk relationship between Alzheimer's disease/Parkinson's disease and cancer

Hang Z, Lei T, Zeng Z, Cai S, Bi W, Du H.

Biomed Pharmacother. 2022 Jan;145:112343. doi: 10.1016/j.biopha.2021.112343. Epub 2021 Dec 1.

PET imaging of reactive astrocytes in neurological disorders

Liu Y, Jiang H, Qin X, Tian M, Zhang H.

Eur J Nucl Med Mol Imaging. 2022 Mar;49(4):1275-1287. doi: 10.1007/s00259-021-05640-5. Epub 2021 Dec 7.

A mechanistic survey of Alzheimer's disease

Tang Y, Zhang D, Gong X, Zheng J.

Biophys Chem. 2022 Feb;281:106735. doi: 10.1016/j.bpc.2021.106735. Epub 2021 Nov 30.

[Sleep disorders in patients with a neurocognitive disorder]

Moderie C, Carrier J, Dang-Vu TT.

Encephale. 2022 Jun;48(3):325-334. doi: 10.1016/j.encep.2021.08.014. Epub 2021 Dec 14.

Targeting disorders in unstructured and structured proteins in various diseases

Choudhary S, Lopus M, Hosur RV.

Biophys Chem. 2022 Feb;281:106742. doi: 10.1016/j.bpc.2021.106742. Epub 2021 Dec 11.

Possible association between PM(2.5) and neurodegenerative diseases: A systematic review

Cristaldi A, Fiore M, Oliveri Conti G, Pulvirenti E, Favara C, Grasso A, Copat C, Ferrante M.

Environ Res. 2022 May 15;208:112581. doi: 10.1016/j.envres.2021.112581. Epub 2021 Dec 31.

Gut Microbiota: A Key Regulator in the Effects of Environmental Hazards on Modulates Insulin Resistance

Huang R.

Front Cell Infect Microbiol. 2022 Jan 17;11:800432. doi: 10.3389/fcimb.2021.800432. eCollection 2021.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias